Tasisulam SodiumProduct ingredient for Tasisulam

Name
Tasisulam Sodium
Drug Entry
Tasisulam

Tasisulam has been used in trials studying the treatment and basic science of Melanoma, Lymphoma, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.

Accession Number
DBSALT002109
Structure
Synonyms
Not Available
UNII
O3955SHR9J
CAS Number
519055-63-1
Weight
Average: 437.08
Monoisotopic: 434.816898
Chemical Formula
C11H5BrCl2NNaO3S2
InChI Key
JCOHXVDKRMWUQP-UHFFFAOYSA-M
InChI
InChI=1S/C11H6BrCl2NO3S2.Na/c12-9-3-4-10(19-9)20(17,18)15-11(16)7-2-1-6(13)5-8(7)14;/h1-5H,(H,15,16);/q;+1/p-1
IUPAC Name
sodium [(5-bromothiophen-2-yl)sulfonyl](2,4-dichlorobenzoyl)azanide
SMILES
[Na+].ClC1=CC(Cl)=C(C=C1)C(=O)[N-]S(=O)(=O)C1=CC=C(Br)S1
ChemSpider
8335745
ChEMBL
CHEMBL2103823
Predicted Properties
PropertyValueSource
Water Solubility0.0043 mg/mLALOGPS
logP3.67ALOGPS
logP4.51Chemaxon
logS-5ALOGPS
pKa (Strongest Acidic)4.03Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count4Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area60.44 Å2Chemaxon
Rotatable Bond Count2Chemaxon
Refractivity80.31 m3·mol-1Chemaxon
Polarizability33.69 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterYesChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleNoChemaxon